Dvir Doron

Title: Dvir Doron: Innovator in Drug Conjugates

Introduction

Dvir Doron is an accomplished inventor based in Giv′at-Shmuel, Israel. He holds a patent that showcases his innovative contributions to the field of drug development. His work focuses on the creation of drug conjugates that have significant potential in cancer treatment and cosmetic applications.

Latest Patents

Dvir Doron is credited with a patent for "5-aminolevulinic acid derivatives, methods for their preparation and uses thereof." This invention provides drug conjugates comprising 5-aminolevulinic acid (ALA), an aldehyde, and a carboxylic acid that may function as a histone deacetylase inhibitor (HDACI). These conjugates are designed to release multiple active species in vivo, making them valuable for the treatment or prevention of cancer in both PDT-dependent and non-PDT treatments. Additionally, the invention outlines novel uses for both new and known compounds, including applications for treating anemia and inducing erythropoiesis.

Career Highlights

Dvir Doron has made significant strides in his career, particularly through his work at Bar-Ilan University and Ramot at Tel-Aviv University Ltd. His research and innovations have contributed to advancements in medical treatments and drug development.

Collaborations

Dvir has collaborated with notable colleagues, including Ada Rephaeli and Nataly Tarasenko. These partnerships have further enhanced his research and the impact of his inventions.

Conclusion

Dvir Doron is a notable inventor whose work in drug conjugates has the potential to revolutionize treatment options for cancer and other medical conditions. His innovative spirit and dedication to research continue to drive advancements in the field.